Naomi S. Coombes

Manor Farm Road, Porton Down
Salisbury, ENG SP40JG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Modelling SARS-CoV-2 infection in a human alveolus microphysiological system.

Modelling SARS-CoV-2 infection in a human alveolus microphysiological system.

Journal: Access microbiology
Published: March 13, 2024

Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.

Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 06, 2023

The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection.

The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection.

Journal: Viruses
Published: April 20, 2023

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum.

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum.

Journal: Viruses
Published: January 27, 2023

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents.

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents.

Journal: Viruses
Published: January 18, 2023

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.

Journal: PLoS pathogens
Published: August 23, 2022

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.

Journal: ACS central science
Published: October 21, 2021

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.

Journal: eLife
Published: April 13, 2021

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

Journal: Cell
Published: February 08, 2021

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Journal: Nature structural & molecular biology
Published: February 04, 2021

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

Journal: Cell
Published: January 29, 2021

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.

Journal: Nature protocols
Published: December 07, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026